My name is Farshad Guirakhoo,
and I am Chief Technology Officer at Vaxess Technologies located
in Cambridge, Massachusetts.
I will be talking about replication
competent viral vectors.
I will be talking about virus
classification, infectious diseases
in humans caused by viruses, and vaccine approaches
to combat such diseases.
Next, I will focus on vaccines based
on viral vectors, general barriers
and challenges, then describe
and challenges for both
and replication-competent vectors.
The talk will be then
vectors, starting with describing
the rationale for this selections,
and going onto a few examples
of replication-competent vectors
which are either in clinical
development or already marketed.
These include VSV, or vesicular stomach virus,
or yellow fever-based replication-competent vectors.
A summary slide will conclude this presentation.